New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 20, 2014
08:07 EDTSTEMStemCells closes enrollment in Phase I/II AMD trial
StemCells announced that based on positive interim results, it has closed enrollment in its Phase I/II clinical trial for dry age-related macular degeneration, or AMD, in order to focus its efforts on a follow-on Phase II randomized, controlled proof-of-concept study, later this year. Interim results for the current AMD trial show a 70% reduction in the rate of geographic atrophy as compared to the control eye and a 65% reduction in the rate of GA as compared to the expected natural history of the disease following a single dose of the Company's proprietary HuCNS-SC human neural stem cells. In addition to these initial efficacy findings, the Phase I/II trial has also demonstrated a favorable safety profile for HuCNS-SC as a treatment for dry AMD. Final results from this landmark study are expected to be released mid-2015.
News For STEM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 24, 2015
10:35 EDTSTEMStemCells appoints Ian Massey as President and COO effective March 23
Subscribe for More Information
March 16, 2015
16:23 EDTSTEMStemCells reports Q4 EPS (14c), one estimate (4c)
Reports Q4 revenue $883K vs 45K in Q413. "Total revenue from continuing operations during the fourth quarter of 2014 was $883,000, compared to $45,000 in the same period of 2013. Revenue from continuing operations is primarily from royalties and milestone payments received under various licensing agreements. The increase in 2014 was primarily attributable to a milestone payment of approximately $500,000 received under a licensing agreement with ReNeuron Ltd. and a licensing fee of approximately $400,000 in connection with our divestiture of the SC Proven business entered into with Takara Bio Inc., a publicly traded Japanese company."

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use